Submitted by reuters8361 in business
Japan's Eisai <a href="https://www.reuters.com/markets/companies/4523.T" target="_blank">(4523.T)</a> said on Monday its Alzheimer's treatment developed with Biogen <a href="https://www.reuters.com/markets/companies/BIIB.O" target="_blank">(BIIB.O)</a>, Leqem…